Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Jul;59(1):45–51.

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

P W Miller 1, A Hamosh 1, M Macek Jr 1, P A Greenberger 1, J MacLean 1, S M Walden 1, R G Slavin 1, G R Cutting 1
PMCID: PMC1915108  PMID: 8659542

Abstract

The etiology of allergic bronchopulmonary aspergillosis (ABPA) is not well understood. A clinical phenotype resembling the pulmonary disease seen in cystic fibrosis (CF) patients can occur in some individuals with ABPA. Reports of familial occurrence of ABPA and increased incidence in CF patients suggest a possible genetic basis for the disease. To test this possibility, the entire coding region of the cystic fibrosis transmembrane regulator (CFTR) gene was analyzed in 11 individuals who met strict criteria for the diagnosis of ABPA and had normal sweat electrolytes (< or = 40 mmol/liter). One patient carried two CF mutations (deltaF508/R347H), and five were found to carry one CF mutation (four deltaF508; one R117H). The frequency of the deltaF508 mutation in patients with ABPA was significantly higher than in 53 Caucasian patients with chronic bronchitis (P < .0003) and the general population (P < .003). These results suggest that CFTR plays an etiologic role in a subset of ABPA patients.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anguiano A., Oates R. D., Amos J. A., Dean M., Gerrard B., Stewart C., Maher T. A., White M. B., Milunsky A. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA. 1992 Apr 1;267(13):1794–1797. [PubMed] [Google Scholar]
  2. Artlich A., Boysen A., Bunge S., Entzian P., Schlaak M., Schwinger E. Common CFTR mutations are not likely to predispose to chronic bronchitis in northern Germany. Hum Genet. 1995 Feb;95(2):226–228. doi: 10.1007/BF00209408. [DOI] [PubMed] [Google Scholar]
  3. Batten J. C. Allergic aspergillosis in cystic fibrosis. Bibl Paediatr. 1967;86:227–236. [PubMed] [Google Scholar]
  4. Brueton M. J., Ormerod L. P., Shah K. J., Anderson C. M. Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood. Arch Dis Child. 1980 May;55(5):348–353. doi: 10.1136/adc.55.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 45-1993. A 23-year-old asthmatic man with pulmonary infiltrates and hilar lymphadenopathy. N Engl J Med. 1993 Nov 11;329(20):1484–1491. doi: 10.1056/NEJM199311113292009. [DOI] [PubMed] [Google Scholar]
  6. Chillón M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., Romey M. C., Ruiz-Romero J., Verlingue C., Claustres M. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995 Jun 1;332(22):1475–1480. doi: 10.1056/NEJM199506013322204. [DOI] [PubMed] [Google Scholar]
  7. Chu C. S., Trapnell B. C., Curristin S. M., Cutting G. R., Crystal R. G. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest. 1992 Sep;90(3):785–790. doi: 10.1172/JCI115952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Costes B., Girodon E., Ghanem N., Flori E., Jardin A., Soufir J. C., Goossens M. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet. 1995;3(5):285–293. doi: 10.1159/000472312. [DOI] [PubMed] [Google Scholar]
  9. Cutting G. R., Curristin S. M., Nash E., Rosenstein B. J., Lerer I., Abeliovich D., Hill A., Graham C. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet. 1992 Jun;50(6):1185–1194. [PMC free article] [PubMed] [Google Scholar]
  10. Cutting G. R., Kasch L. M., Rosenstein B. J., Zielenski J., Tsui L. C., Antonarakis S. E., Kazazian H. H., Jr A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 1990 Jul 26;346(6282):366–369. doi: 10.1038/346366a0. [DOI] [PubMed] [Google Scholar]
  11. Davis P. B. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis. 1984 Jun;129(6):911–914. doi: 10.1164/arrd.1984.129.6.911. [DOI] [PubMed] [Google Scholar]
  12. Davis P. B., Hubbard V. S., Di Sant'Agnese P. A. Low sweat electrolytes in a patient with cystic fibrosis. Am J Med. 1980 Oct;69(4):643–646. doi: 10.1016/0002-9343(80)90482-9. [DOI] [PubMed] [Google Scholar]
  13. Davis P. B., Vargo K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax. 1987 Feb;42(2):120–125. doi: 10.1136/thx.42.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Erlich H. A., Gelfand D., Sninsky J. J. Recent advances in the polymerase chain reaction. Science. 1991 Jun 21;252(5013):1643–1651. doi: 10.1126/science.2047872. [DOI] [PubMed] [Google Scholar]
  15. Gabriel S. E., Brigman K. N., Koller B. H., Boucher R. C., Stutts M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 1994 Oct 7;266(5182):107–109. doi: 10.1126/science.7524148. [DOI] [PubMed] [Google Scholar]
  16. Gervais R., Lafitte J. J., Dumur V., Kesteloot M., Lalau G., Houdret N., Roussel P. Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis. Lancet. 1993 Oct 16;342(8877):997–997. doi: 10.1016/0140-6736(93)92046-v. [DOI] [PubMed] [Google Scholar]
  17. Graves T. S., Fink J. N., Patterson R., Kurup V. P., Scanlon G. T. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1979 Sep;91(3):378–382. doi: 10.7326/0003-4819-91-3-378. [DOI] [PubMed] [Google Scholar]
  18. Greenberger P. A. Allergic bronchopulmonary aspergillosis and fungoses. Clin Chest Med. 1988 Dec;9(4):599–608. [PubMed] [Google Scholar]
  19. Greenberger P. A., Patterson R. Application of enzyme-linked immunosorbent assay (ELISA) in diagnosis of allergic bronchopulmonary aspergillosis. J Lab Clin Med. 1982 Feb;99(2):288–293. [PubMed] [Google Scholar]
  20. Gregg R. G., Wilfond B. S., Farrell P. M., Laxova A., Hassemer D., Mischler E. H. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. Am J Hum Genet. 1993 Mar;52(3):616–626. [PMC free article] [PubMed] [Google Scholar]
  21. Halwig J. M., Kurup V. P., Greenberger P. A., Patterson R. A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source. J Allergy Clin Immunol. 1985 Jul;76(1):55–59. doi: 10.1016/0091-6749(85)90804-8. [DOI] [PubMed] [Google Scholar]
  22. Hammond K. B., Abman S. H., Sokol R. J., Accurso F. J. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med. 1991 Sep 12;325(11):769–774. doi: 10.1056/NEJM199109123251104. [DOI] [PubMed] [Google Scholar]
  23. Highsmith W. E., Burch L. H., Zhou Z., Olsen J. C., Boat T. E., Spock A., Gorvoy J. D., Quittel L., Friedman K. J., Silverman L. M. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994 Oct 13;331(15):974–980. doi: 10.1056/NEJM199410133311503. [DOI] [PubMed] [Google Scholar]
  24. Hutcheson P. S., Rejent A. J., Slavin R. G. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol. 1991 Sep;88(3 Pt 1):390–394. doi: 10.1016/0091-6749(91)90102-t. [DOI] [PubMed] [Google Scholar]
  25. Kazazian H. H., Jr The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol. 1990 Jul;27(3):209–228. [PubMed] [Google Scholar]
  26. Kerem B. S., Zielenski J., Markiewicz D., Bozon D., Gazit E., Yahav J., Kennedy D., Riordan J. R., Collins F. S., Rommens J. M. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8447–8451. doi: 10.1073/pnas.87.21.8447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  28. Kiesewetter S., Macek M., Jr, Davis C., Curristin S. M., Chu C. S., Graham C., Shrimpton A. E., Cashman S. M., Tsui L. C., Mickle J. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet. 1993 Nov;5(3):274–278. doi: 10.1038/ng1193-274. [DOI] [PubMed] [Google Scholar]
  29. Knowles M. R., Barnett T. B., McConkie-Rosell A., Sawyer C., Kahler S. G. Mild cystic fibrosis in a consanguineous family. Ann Intern Med. 1989 Apr 15;110(8):599–605. doi: 10.7326/0003-4819-110-8-599. [DOI] [PubMed] [Google Scholar]
  30. Knowles M. R., Paradiso A. M., Boucher R. C. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther. 1995 Apr;6(4):445–455. doi: 10.1089/hum.1995.6.4-445. [DOI] [PubMed] [Google Scholar]
  31. Kristidis P., Bozon D., Corey M., Markiewicz D., Rommens J., Tsui L. C., Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992 Jun;50(6):1178–1184. [PMC free article] [PubMed] [Google Scholar]
  32. Laufer P., Fink J. N., Bruns W. T., Unger G. F., Kalbfleisch J. H., Greenberger P. A., Patterson R. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):44–48. doi: 10.1016/0091-6749(84)90482-2. [DOI] [PubMed] [Google Scholar]
  33. Murphy S. Cystic fibrosis in adults: diagnosis and management. Clin Chest Med. 1987 Dec;8(4):695–710. [PubMed] [Google Scholar]
  34. Nelson L. A., Callerame M. L., Schwartz R. H. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis. 1979 Oct;120(4):863–873. doi: 10.1164/arrd.1979.120.4.863. [DOI] [PubMed] [Google Scholar]
  35. Osborne L. R., Lynch M., Middleton P. G., Alton E. W., Geddes D. M., Pryor J. P., Hodson M. E., Santis G. K. Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet. 1993 Oct;2(10):1605–1609. doi: 10.1093/hmg/2.10.1605. [DOI] [PubMed] [Google Scholar]
  36. Pignatti P. F., Bombieri C., Marigo C., Benetazzo M., Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet. 1995 Apr;4(4):635–639. doi: 10.1093/hmg/4.4.635. [DOI] [PubMed] [Google Scholar]
  37. Poller W., Faber J. P., Scholz S., Olek K., Müller K. M. Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course. Klin Wochenschr. 1991 Sep 16;69(14):657–663. doi: 10.1007/BF01649427. [DOI] [PubMed] [Google Scholar]
  38. Ranieri E., Ryall R. G., Morris C. P., Nelson P. V., Carey W. F., Pollard A. C., Robertson E. F. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ. 1991 May 25;302(6787):1237–1240. doi: 10.1136/bmj.302.6787.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rave-Harel N., Madgar I., Goshen R., Nissim-Rafinia M., Ziadni A., Rahat A., Chiba O., Kalman Y. M., Brautbar C., Levinson D. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet. 1995 Jun;56(6):1359–1366. [PMC free article] [PubMed] [Google Scholar]
  40. Rosenberg M., Patterson R., Mintzer R., Cooper B. J., Roberts M., Harris K. E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977 Apr;86(4):405–414. doi: 10.7326/0003-4819-86-4-405. [DOI] [PubMed] [Google Scholar]
  41. Shah A., Khan Z. U., Chaturvedi S., Malik G. B., Randhawa H. S. Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. Ann Allergy. 1990 Jun;64(6):507–512. [PubMed] [Google Scholar]
  42. Strong T. V., Smit L. S., Turpin S. V., Cole J. L., Hon C. T., Markiewicz D., Petty T. L., Craig M. W., Rosenow E. C., 3rd, Tsui L. C. Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels. N Engl J Med. 1991 Dec 5;325(23):1630–1634. doi: 10.1056/NEJM199112053252307. [DOI] [PubMed] [Google Scholar]
  43. Tsui L. C. The spectrum of cystic fibrosis mutations. Trends Genet. 1992 Nov;8(11):392–398. doi: 10.1016/0168-9525(92)90301-j. [DOI] [PubMed] [Google Scholar]
  44. Zielenski J., Patrizio P., Corey M., Handelin B., Markiewicz D., Asch R., Tsui L. C. CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet. 1995 Oct;57(4):958–960. [PMC free article] [PubMed] [Google Scholar]
  45. Zielenski J., Rozmahel R., Bozon D., Kerem B., Grzelczak Z., Riordan J. R., Rommens J., Tsui L. C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991 May;10(1):214–228. doi: 10.1016/0888-7543(91)90503-7. [DOI] [PubMed] [Google Scholar]
  46. Zielenski J., Rozmahel R., Bozon D., Kerem B., Grzelczak Z., Riordan J. R., Rommens J., Tsui L. C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991 May;10(1):214–228. doi: 10.1016/0888-7543(91)90503-7. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES